Advance Search | Bentham Science

PI3K Inhibitors for Cancer Therapy: What has been Achieved So Far?

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 8 Year: 2009 Page: 916-930
Author(s): Peng Wu, Tao Liu, Yongzhou Hu

Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) δ and γ

Journal: Current Topics in Medicinal Chemistry
Volume: 9 Issue: 8 Year: 2009 Page: 738-753
Author(s): Michael K. Ameriks, Jennifer D. Venable

The PI3K/Akt Pathway as a Target in the Treatment of Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2009 Page: 550-559
Author(s): Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka, Osamu Yamada

Targeted Therapy for Advanced Prostate Cancer: Inhibition of the PI3K/Akt/mTOR Pathway

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 237-249
Author(s): Todd M. Morgan, Theodore D. Koreckij, Eva Corey

Regulation and Importance of the PI3K/Akt/mTOR Signaling Pathway in Hematologic Malignancies

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9 Issue: 9 Year: 2009 Page: 1024-1038
Author(s): Kiyotaka Kawauchi, Toshie Ogasawara, Masako Yasuyama, Kuniaki Otsuka, Osamu Yamada

Advances in Development of Phosphatidylinositol 3-Kinase Inhibitors

Journal: Current Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2009 Page: 2839-2854
Author(s): Dexin Kong, Takao Yamori

Post-Wortmannin Era: Novel Phosphoinositide 3-Kinase Inhibitors with Potential Therapeutic Applications

Journal: Current Enzyme Inhibition
Volume: 5 Issue: 2 Year: 2009 Page: 66-86
Author(s): Laura Braccini, Fulvio Morello, Alessia Perino, Emilio Hirsch

Role of PI3K/AKT, cPLA2 and ERK1/2 Signaling Pathways in Insulin Regulation of Vascular Smooth Muscle Cells Proliferation

Journal: Cardiovascular & Hematological Disorders-Drug Targets
Volume: 9 Issue: 3 Year: 2009 Page: 172-180
Author(s): Esma R. Isenovic, Mamdouh H. Kedees, Snezana Tepavcevic, Tijana Milosavljevic, Goran Koricanac, Andreja Trpkovic, Pierre Marche

PI3K/Akt/JNK/c-Jun Signaling Pathway is a Mediator for Arsenite- Induced Cyclin D1 Expression and Cell Growth in Human Bronchial Epithelial Cells

Journal: Current Cancer Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 500-509
Author(s): Jin Ding, Beifang Ning, Yi Huang, Dongyun Zhang, Jingxia Li, Chang-Yan Chen, Chuanshu Huang

Signaling Intermediates (PI3K/PTEN/AKT/mTOR and RAF/MEK/ERK Pathways) as Therapeutic Targets for Anti-Cancer and Anti-Angiogenesis Treatments

Journal: Current Signal Transduction Therapy
Volume: 4 Issue: 2 Year: 2009 Page: 130-143
Author(s): Ludovica Ciuffreda, James A. McCubrey, Michele Milella

Search

Find Journals, Volumes, Issues, Articles, Ebooks and Chapters

Search Result "PI3K�� inhibitors"